Agalimmune

Agalimmune was established in 2013 Its shareholders include Loxbridge Research LLP.

Launch date

2013

Employees

Market cap

Enterprise valuation

€5m (Public information from Mar 2017)

Irvine California (HQ)

Date	Investors	Amount	Round
Mar 2017	BiolineRx	$6.0m Valuation: $6.0m	Acquisition
Total Funding		-

Recent News about Agalimmune